Usefulness of a Visual Analog Scale for Measuring Anxiety in Hospitalized Patients Experiencing Pain: A Multicenter Cross-Sectional Study

Ducoulombier, Vincent; Chiquet, Roman; S, Graf; Leroy, B.; Bouquet, Guillaume; Verdun, Stéphane; Martellier, Fabienne; Versavel, Adeline; Kone, Alexandre; Lacroix, Karine; Duthoit, Didier; Lenglet, Quentin; Devaux, Amelie; Jeanson, Robert; Lefebvre, Antoine; Coviaux, Benoit; Calais, Gauthier; Grimbert, Adeline; Ledein, Marie; Moukagni, M; Pascart, Tristan; Houvenagel, É.

doi:10.1016/j.pmn.2020.03.004

Cited by 14 publications

(12 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Recent advances for patients with rheumatic diseases include more treatment options with improved outcomes, yet there remains an unmet need with pain (1)(2)(3)(4). While pain is sometimes treated as a single dimension of a patient's health-related quality of life, many patients with chronic pain also experience associated symptoms in other dimensions including insomnia, anxiety, and depression (5)(6)(7)(8)(9)(10). Pain control is listed as one of the highest priorities by patients with rheumatoid arthritis (RA) (11); these patients often turn to alternative treatments to cope with pain, including acupuncture/acupressure, hypnosis, herbal therapies, and cannabis (12)(13)(14)(15)(16)(17).…”

Section: Introductionmentioning

confidence: 99%

Increase in Cannabis Use Among Adults With Rheumatic Diseases: Results From a 2014–2019 United States Observational Study

Wipfler

Simon

Katz

et al. 2022

Arthritis Care & Research

View full text Add to dashboard Cite

Objective. Despite advances in treatments and outcomes among patients with rheumatic diseases, there is an unmet need in pain management. Cannabis has emerged as a potential opioid-sparing alternative, with arthritic pain as a commonly cited reason for medicinal cannabis use. However, little is known, and we set out to understand patterns of cannabis use in a US-wide rheumatic disease population.Methods. The study included participants in FORWARD, The National Databank for Rheumatic Diseases. Participants were asked in 2014 and 2019 about their past and current cannabis use. Demographic characteristics, patient-reported outcomes, medications, comorbidities, and diagnoses were compared between cannabis users and non-users with t-tests, chi-square tests, logistic regression, and geographic assessment.Results. Among 11,006 respondents, cannabis use increased from 6.3% in 2014 to 18.4% in 2019, with the greatest prevalence of use in states where cannabis use was legalized. Most users (74% and 62% in 2014 and 2019, respectively) reported that cannabis was effective in the relief of arthritis symptoms. Cannabis users were more likely to be taking weak opioids (odds ratio 1.2 [95% confidence interval 1.0, 1.5], P = 0.03), to have a history of smoking tobacco (odds ratio 1.7 [95% confidence interval 1.5, 2.1], P < 0.001), and had worse measures on all assessed patient-reported outcomes.Conclusion. Reported cannabis use in this cohort increased significantly between 2014 and 2019. Characteristics of users suggest that those who try cannabis are feeling worse symptomatically, and their pain management needs may not be adequately addressed by other therapies. The association between cannabis, opioids, and patientreported outcomes highlight areas for future work.

show abstract

Section: Introductionmentioning

confidence: 99%

Increase in Cannabis Use Among Adults With Rheumatic Diseases: Results From a 2014–2019 United States Observational Study

Wipfler

Simon

Katz

et al. 2022

Arthritis Care & Research

View full text Add to dashboard Cite

show abstract

“…We measured location of points to 1 [mm] accuracy. Thus, this results became 101points scale from 0 to 100 points (13,14) .…”

Section: Methodsmentioning

confidence: 98%

Relationship between Creative Inspiration, Self-Evaluated Satisfaction and Brain Activity through Simplified Music Composition

Sato

Chiba

Moriya

et al. 2021

The Proceedings of the 9th IIAE International Conference on Industrial Application Engineering 2020

View full text Add to dashboard Cite

The human prefrontal cortex (PFC) is an important target for a research which attempt to elucidate and control at will of higher brain function using non-invasive neuroimaging techniques. In particular, creativity is specific higher human brain function and integral for evolution of human society. Creative inspirations generated during creative activity often solve hard problems and lead us in the good direction. The present study examined the PFC activity when creative inspiration happened and an influence of difference of brain activity on quality of creation, using the simplified music composition task and near infrared spectroscopy (NIRS). Deeply understanding these brain function possibly builds a foundation for development of methods to stimulate brain activation for creativity.The PFC activity measurements were achieved by measuring oxygen metabolism in cerebral blood flow (CBF) using 10-channel wearable optical topography (WOT-100, NeU Ltd.). We invested new simplified method of music composition to analyze brain activity of a person without instruments experience. A report of creative inspirations was conducted by raising subject's hand as possible as small during the music composition task and we compared statistically brain activity of before and after inspirations. Correlation coefficient between brain activity and selfevaluation measured by visual analog scale (VAS) was investigated.The present research found that right ventrolateral PFC is activated by creative inspiration. Significant brain activation of 4 subjects out of participated 5 subjects was observed (p < 0.05). The CBF increases delayed from inspirations and mean delay time was approximately 12 seconds. We observed weak positive correlation between brain activity and self-evaluation in a wide range. However, correlation coefficient was not statistically significant (p > 0.05). Simplification of music composition task possibly mask clear correlation. In conclusion, the main finding that right PFC activation by inspirations indicated important mechanism of creativity.

show abstract

“…Patient-reported anxiety intensity level over time is measured three times daily with a visual analogue scale-anxiety (VAS-A). The VAS-A is a valid, non-burdensome single-item instrument to measure anxiety intensity over repeated assessments in mechanically ventilated patients [ 8 – 11 ]. VAS-A intensity scores range from 0 to 100 mm.…”

Section: Methods: Participants Interventions and Outcomesmentioning

confidence: 99%

Study protocol to test the efficacy of self-administration of dexmedetomidine sedative therapy on anxiety, delirium, and ventilator days in critically ill mechanically ventilated patients: an open-label randomized clinical trial

Chlan

Weinert

Tracy

et al. 2022

Trials

View full text Add to dashboard Cite

Background Administration of sedative and opioid medications to patients receiving mechanical ventilatory support in the intensive care unit is a common clinical practice. Methods A two-site randomized open-label clinical trial will test the efficacy of self-management of sedative therapy with dexmedetomidine compared to usual care on anxiety, delirium, and duration of ventilatory support after randomization. Secondary objectives are to compare self-management of sedative therapy to usual care on level of alertness, total aggregate sedative and opioid medication exposure, and ventilator-free days up to day 28 after study enrolment. Exploratory objectives of the study are to compare self-management of sedative therapy to usual care on 3- and 6-month post-discharge physical and functional status, psychological well-being (depression, symptoms of post-traumatic stress disorder), health-related quality of life, and recollections of ICU care. ICU patients (n = 190) who are alert enough to follow commands to self-manage sedative therapy are randomly assigned to self-management of sedative therapy or usual care. Patients remain in the ICU sedative medication study phase for up to 7 days as long as mechanically ventilated. Discussion The care of critically ill mechanically ventilated patients can change significantly over the course of a 5-year clinical trial. Changes in sedation and pain interventions, oxygenation approaches, and standards related to extubation have substantially impacted consistency in the number of eligible patients over time. In addition, the COVID-19 pandemic resulted in mandated extended pauses in trial enrolment as well as alterations in recruitment methods out of concern for study personnel safety and availability of protective equipment. Patient triaging among healthcare institutions due to COVID-19 cases also has resulted in inconsistent access to the eligible study population. This has made it even more imperative for the study team to be flexible and innovative to identify and enrol all eligible participants. Patient-controlled sedation is a novel approach to the management of patient symptoms that may be able to alleviate mechanical ventilation-induced distress without serious side effects. Findings from this study will provide insight into the efficacy of this approach on short- and long-term outcomes in a subset of mechanically ventilated patients. Trial registration ClinicalTrials.gov NCT02819141. Registered on June 29, 2016.

show abstract

Usefulness of a Visual Analog Scale for Measuring Anxiety in Hospitalized Patients Experiencing Pain: A Multicenter Cross-Sectional Study

Cited by 14 publications

References 23 publications

Increase in Cannabis Use Among Adults With Rheumatic Diseases: Results From a 2014–2019 United States Observational Study

Increase in Cannabis Use Among Adults With Rheumatic Diseases: Results From a 2014–2019 United States Observational Study

Relationship between Creative Inspiration, Self-Evaluated Satisfaction and Brain Activity through Simplified Music Composition

Study protocol to test the efficacy of self-administration of dexmedetomidine sedative therapy on anxiety, delirium, and ventilator days in critically ill mechanically ventilated patients: an open-label randomized clinical trial

Contact Info

Product

Resources

About